Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate Immunogenicity and Safety of Boostrix Compared to Adacel When Administered as a Booster Vaccination in Adults Aged 19 to 64 Years of Age

NCT00346073 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00346073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00346073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate Immunogenicity and Safety of Boostrix Compared to Adacel When Administered as a Booster Vaccination in Adults Aged 19 to 64 Years of Age
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
July 13, 2006
Completion date
March 7, 2007
Enrollment
2,337 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

acellular pertussis, diphtheria, tetanus